Eradication of mycobacterium abscessus in a chronically infected patient with cystic fibrosis.
Colin
A A
AA
D000280:Administration, Inhalation; D000284:Administration, Oral; D000328:Adult; D000583:Amikacin / Q000008:administration & dosage / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D017291:Clarithromycin / Q000008:administration & dosage / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000150:complications* / Q000382:microbiology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008169:Lung Abscess / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D009161:Mycobacterium / Q000187:drug effects / Q000472:pathogenicity; D009164:Mycobacterium Infections / Q000188:drug therapy* / Q000473:pathology; D012008:Recurrence
D000900:Anti-Bacterial Agents; D000583:Amikacin; D017291:Clarithromycin